Therapeutic implications of the prostaglandin pathway in Alzheimer's disease.
about
Aspirin and anti-inflammatory drugs for the prevention of dementiaNeuroinflammation and J2 prostaglandins: linking impairment of the ubiquitin-proteasome pathway and mitochondria to neurodegeneration.Different mechanisms of apolipoprotein E isoform-dependent modulation of prostaglandin E2 production and triggering receptor expressed on myeloid cells 2 (TREM2) expression after innate immune activation of microglia.Progressive inflammatory pathology in the retina of aluminum-fed 5xFAD transgenic mice.Pro-Resolving Lipid Mediators Improve Neuronal Survival and Increase Aβ42 PhagocytosisThe Relation between canine cognitive dysfunction and age-related brain lesions.PGE2-EP3 signaling pathway contributes to protective effects of misoprostol on cerebral injury in APP/PS1 miceGABAergic neurotransmission and new strategies of neuromodulation to compensate synaptic dysfunction in early stages of Alzheimer's disease.Alzheimer's disease and chronic periodontitis: is there an association?Nonsteroidal Anti-Inflammatory Therapy: A Journey Toward Safety.Involvement of inflammation in Alzheimer's disease pathogenesis and therapeutic potential of anti-inflammatory agents.Derivation and Evaluation of Putative Adverse Outcome Pathways for the Effects of Cyclooxygenase Inhibitors on Reproductive Processes in Female Fish.Activation of Hippocampal CREB by Rolipram Partially Recovers Balance Between TNF-α and IL-10 Levels and Improves Cognitive Deficits in Diabetic Rats.Anemoside A3 ameliorates experimental autoimmune encephalomyelitis by modulating T helper 17 cell response.An evaluation of progressive amyloidogenic and pro-inflammatory change in the primary visual cortex and retina in Alzheimer's disease (AD).Activation of EP2 receptor suppresses poly(I: C) and LPS-mediated inflammation in primary microglia and organotypic hippocampal slice cultures: Contributing role for MAPKs.Involvement of Astrocytes in Alzheimer's Disease from a Neuroinflammatory and Oxidative Stress Perspective.Prostaglandin J2 promotes O-GlcNAcylation raising APP processing by α- and β-secretases: relevance to Alzheimer's disease.M2 Macrophage Transplantation Ameliorates Cognitive Dysfunction in Amyloid-β-Treated Rats Through Regulation of Microglial Polarization.Tocotrienol-Rich Fraction of Palm Oil Improves Behavioral Impairments and Regulates Metabolic Pathways in AβPP/PS1 Mice.Effects of Nonsteroidal Anti-Inflammatory Drugs at the Molecular Level.
P2860
Q24186992-252E1DBB-2E84-4665-831B-FC648D38BB42Q34933261-3ED79DCA-F0A0-49AD-9F50-460D9033B59EQ35555134-AD2755B4-00E2-4308-ABCB-F7E2D8AFE7F6Q36378098-CD85C64E-E02E-4828-A7FC-C2F70E23A211Q36777563-72BBF7EF-ADD6-49EF-BDFB-73D0BCE9F25AQ37075814-1E0FDC37-937F-492C-9DAC-0B5A1BEFCDE1Q37295322-6FD01D91-9002-408C-964B-696B8B47CEF2Q38225536-D47BDF3B-0606-4355-A4FE-01A3B70668CAQ38289481-0BA0530C-C6F1-45C4-B8F3-8C285FD8235EQ38558587-3DF6D0CC-81D5-4109-94D6-AAE429B4E6CBQ38569669-D55AB36A-C111-42C5-85F4-B53972F54C4CQ38959910-1AC6E160-4D7D-422D-8116-02078ABDF756Q40910506-EDFFC30F-6C0B-4683-9870-3BDAD6291C8DQ41185707-9965BF29-43F0-4739-A827-344DE530A3FFQ41645975-FCBE7F11-0650-494A-AB0A-868023AF7358Q47309400-00B6D518-33DA-4B2D-BCEA-80DB4D943B73Q47370188-D7AB4FE3-7885-4DAD-8F70-E46510243627Q47391212-6A02C40C-41C6-483D-A9DF-3F480BB7A8E3Q48818944-D5F984F5-139B-4924-B2DD-FE164B0F3C99Q55266361-144414A3-5716-4EA0-B381-4D2885F67B8FQ55531057-64282D6D-F773-439C-A512-045266966AEB
P2860
Therapeutic implications of the prostaglandin pathway in Alzheimer's disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 13 January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Therapeutic implications of the prostaglandin pathway in Alzheimer's disease.
@en
Therapeutic implications of the prostaglandin pathway in Alzheimer's disease.
@nl
type
label
Therapeutic implications of the prostaglandin pathway in Alzheimer's disease.
@en
Therapeutic implications of the prostaglandin pathway in Alzheimer's disease.
@nl
prefLabel
Therapeutic implications of the prostaglandin pathway in Alzheimer's disease.
@en
Therapeutic implications of the prostaglandin pathway in Alzheimer's disease.
@nl
P2093
P2860
P1476
Therapeutic implications of the prostaglandin pathway in Alzheimer's disease.
@en
P2093
Eiron Cudaback
Thomas J Montine
P2860
P304
P356
10.1016/J.BCP.2013.12.014
P407
P577
2014-01-13T00:00:00Z